Vericel Corp. (VCEL)
31.41
-1.33
(-4.06%)
USD |
NASDAQ |
Mar 20, 16:00
31.46
+0.05
(+0.16%)
After-Hours: 20:00
Vericel EPS Diluted (Quarterly) : 0.4464 for Dec. 31, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Arbutus Biopharma Corp. | -0.0404 |
| Moderna, Inc. | -2.107 |
| Marker Therapeutics, Inc. | -0.1022 |
| X4 Pharmaceuticals, Inc. | -0.2164 |
| ACADIA Pharmaceuticals, Inc. | 1.596 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | 23.24M |
| Revenue (Quarterly) | 92.92M |
| Total Expenses (Quarterly) | 69.68M |
| Enterprise Value | 1.555B |
| Gross Profit Margin (Quarterly) | 78.70% |
| Profit Margin (Quarterly) | 25.01% |
| Earnings Yield | 0.98% |
| Operating Earnings Yield | 0.69% |
| Normalized Earnings Yield | 0.9799 |